Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02383628 · ClinicalTrials.gov registry record
Endoscopic Perfusion Utilizing ICG Fluorescence Technology
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 197
- Enrollment target
NCT02383628 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 197 participants.
The verdict
NCT02383628 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 197 participants
- Enrollment target
Study Summary
The main objective of the study is to evaluate the efficacy of indocyanine green (ICG) endoscopy to evaluate tissue perfusion during endoscopic neurosurgery. This includes patients with pituitary and intracranial tumors and treatment of vascular abnormalities such as aneurysms and compressive syndromes. ICG will be evaluated to determine the value of the additional visual information supplied during the treatment of these pathologies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2015-10 |
| Est. Completion | 2018-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02383628
The ClinicalTrials.gov registry entry for NCT02383628 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 197 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02383628 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02383628 about?
NCT02383628 is a clinical study titled "Endoscopic Perfusion Utilizing ICG Fluorescence Technology". The main objective of the study is to evaluate the efficacy of indocyanine green (ICG) endoscopy to evaluate tissue perfusion during endoscopic neurosurgery. This includes patients with pituitary and intracranial tumors and treatment of vascular abnormalities such as aneurysms and compressive syndro...
What is the current status of trial NCT02383628?
This trial is currently completed. The enrollment target is 197 participants. The study started on 2015-10. Estimated completion is 2018-06.
Who is sponsoring clinical trial NCT02383628?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.